Metraipolis › archive › dc_3571e2d62966

Dual PI3K and HDAC inhibitor, CUDC-907, effectively inhibits endometrial cancer growth in vitro and in vivo — Europe PMC PMID:41262902

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41262902
DOI
10.3389/fonc.2025.1531805
License (as archived)
solo-consultazione
Archived
2026-11-08T19:14:55.903Z
SHA-256 of the archived text
ebfebd61438dabe6e6e7b7f97609c2595d1d47ff40c10578b51640de63ba79bb
Stable URL of this page
https://metraipolis.com/documento/dc_3571e2d62966

How to cite

Dual PI3K and HDAC inhibitor, CUDC-907, effectively inhibits endometrial cancer growth in vitro and in vivo — Europe PMC PMID:41262902 — Europe PMC (en), https://europepmc.org/article/MED/41262902 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3571e2d62966 (Metraipolis archive dc_3571e2d62966, sha256 ebfebd61438dabe6e6e7b7f97609c2595d1d47ff40c10578b51640de63ba79bb)
BibTeX
@misc{dc3571e2d62966,
  title = {Dual PI3K and HDAC inhibitor, CUDC-907, effectively inhibits endometrial cancer growth in vitro and in vivo — Europe PMC PMID:41262902},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41262902},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3571e2d62966; sha256 ebfebd61438dabe6e6e7b7f97609c2595d1d47ff40c10578b51640de63ba79bb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41262902. Agents can read the archived copy with the MCP tool read_document.